Feature|Articles|May 14, 2024
- Pharmaceutical Executive: May 2024
- Volume 44
- Issue 5
Pharmaceutical Executive: May 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive May 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 1 year ago
'Patients are Waiting'over 1 year ago
Patient Treatment & Travel: The Need for Stepped-Up Supportover 1 year ago
A Biosimilars Roadmap: Understanding Payer Perceptionsover 1 year ago
Avoiding the Digital Age is Hurting Research Effortsover 1 year ago
Biotech’s Road to Recovery Takes a Wobbly Turnover 1 year ago
Yvonne Greenstreet: Answering the Callalmost 2 years ago
Lessons Learned on the Art and Science of Product CommercializationNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
3
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
4
Taking Advantage of ‘Hidden Gem’ Talent Hubs
5

